Menu

FDA Approves EQUISUL-SDT (Sulfadiazine-Trimethoprim) oral suspension

Product Features

• EQUISUL-SDT is proven effective in horses for the treatment of lower respiratory tract infections caused by susceptible strains of Streptococcus equi subsp. zooepidemicus in controlled field trials.

• EQUISUL-SDT safety was demonstrated in a controlled study in horses at 1X, 3X and 5X the recommended dose for 30 days.

• Easy-to-use liquid formulation.

• Significantly higher bioavailability on a mg-to-mg basis compared to an existing approved paste product, based on a pharmacokinetic crossover study.

• Low incidence of side effects in our controlled safety studies.

280mL Bottle - Reorder No: 28003

560 mL Bottle - Reorder No: 28002

900 mL Bottle — Reorder No: 28001

 

Shopping cart

0 Items $0.00

News

CocciAid (amprolium) 9.6% oral Solution Coccidiostat
SwineMate (alternogest)
Altren (altrenogest)
CLARITY Non-Spermicidal A.I. Lubricating Jelly
BALANCE Stress & Dehydration Aid
FDA Approves EQUISUL-SDT (Sulfadiazine-Trimethoprim) oral suspension
Aurora Pharmaceutical launches ORAL-PRO Vitamin D3 plus E for oral use in swine and in drinking water of nursery and finishing pigs
BARRIER Wound Care with Pain Relief, 2% available iodine plus Lidocaine
Aurora Pharmacuetical Website